CUSIP: G55598109
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,356,592
-
Share change
-
+149,665
-
Total reported value
-
$9,639,000
-
Price per share
-
$0.78
-
Number of holders
-
13
-
Value change
-
+$117,353
-
Number of buys
-
6
-
Number of sells
-
1
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP G55598109:
Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q1 2017
As of 31 Mar 2017,
LOMBARD MED INC - COM (EVAR) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,356,592 shares.
The largest 10 holders included
Invesco Ltd., Abingworth LLP, SV Health Investors, LLC, New Leaf Venture Partners, L.L.C., KCG HOLDINGS, INC., RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, and DEUTSCHE BANK AG\.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.